Skip to main content
search

Strategic Leadership

Sign up

Latest resources

Featured resource

Upcoming strategic leadership webinars

Popular resources

Meet our experts at the following events

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

September 16 - 18, 2026
Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

September 22 - 23, 2026 – Westin Copley Place | Boston, MA
Conference

ISSX 27th North American Meeting

October 11 - 14, 2026 – San Francisco, CA

All Strategic Leadership resources

A glimpse into the future of model-informed drug discovery and development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

Certara Services, Drug Development, Drug Safety, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

MBMA data curation: How AI and expert meta-analysts get it right, fast

Certara Services, Clinical Trials, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - MBMA, Blog

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Certara Services, Drug Development, Model Informed Drug Development, On-Demand Webinar

Important drug development questions that model-based meta-analysis answers

Certara Services, Clinical Pharmacology, Drug Development Support, Model Informed Drug Development, Modeling and Simulation - MBMA, Blog

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Publication

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Conference

Enhancing clinical trials with real-world evidence in pregnancy research

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Real World Evidence, Therapeutic Specialties, Blog

Building IND-Ready and Investor-Ready Development Programs

Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, New Approach Methodologies (NAMs), On-Demand Webinar

Beyond compliance: What ICH M15 means for the future of drug development

Certara Services, Clinical Pharmacology, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Certainty US 2026 recap: Advancing model-informed drug development right from the start

AI & Machine Learning, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.